Tumor microenvironment parameters as a predictor of the duration of clinical effectiveness of immunotargeted therapy in advanced or metastatic endometrial cancer: A pilot multicent... by A. A. Maltseva, A. Yu. Kalinchuk, N. V. Krakhmal, N. M. Chernorubashkina, E. S. Martynova, R. A. Zukov, A. A. Gofman, A. B. Villert, O. N. Churuksaeva, L. A. Kolomiets, L. A. Tashireva

Connect to this object online.

Assessment of <i>ERBB2</i> and HER2 expression in metastatic breast cancer using the nCounter® system and a 100-gene scale by R.  M.  Paltuev, O.  A.  Volynshchikova, Sh.  R.  Abdullaeva, S.  N.  Aleksakhina, A.  S.  Artemyeva, E.  A.  Baychorov, S.  Yu.  Bakharev, Yu.  A.  Belaya, A.  A.  Bozhok, V.  A.  Vasin, V.  I.  Vladimirov, A.  Yu.  Vorontsov, E.  A.  Gaysina, A.  A.  Gofman, V.  N.  Dmitriev, E.  N.  Imyanitov, V.  V.  Klimenko, A.  V.  Komyakhov, M.  M.  Konstantinova, M. V.  Kopp, A.  G.  Kudaybergenova, I.  A.  Lalak, D.  L.  Matevosyan, N.  M.  Mudzhiri, O.  V.  Poltareva, O.  I.  Sevryukova, V.  F.  Semiglazov, T.  Yu.  Semiglazova, M.  M.  Urezkova, A.  S.  Chichkanova, L.  A.  Churilova, M.  V.  Shomova

Connect to this object online.